首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1547303

全球聚乙二醇化市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global PEGylation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球聚乙二醇化市場需求預計將從2023年的20.3億美元達到2032年近58億美元的市場規模，2024-2032年研究期間複合年成長率為12.36%。

聚乙二醇化（或聚乙二醇化）是將聚乙二醇（PEG，在藥學中也稱為聚乙二醇）聚合物鏈以共價和非共價方式連接或合併到分子和宏觀結構（例如藥物、治療性蛋白質或囊泡）的過程。聚乙二醇化通常是透過將目標分子與反應性聚乙二醇衍生物一起孵育來完成。 PEG 與藥物或治療蛋白的共價連接可以「隱藏」宿主免疫系統的藥劑（降低免疫原性和抗原性）並增強其流體動力學尺寸（溶液中的尺寸），從而延長其循環持續時間通過減少腎臟清除率。疏水性藥物和蛋白質也可以進行聚乙二醇化，使其具有水溶性。

市場動態

製藥和生物製藥公司研發投資的增加、生物製品行業的擴張、生活方式疾病盛行率的上升以及對改善蛋白質穩定性和循環半衰期的關注和認知的提高預計將推動市場成長。此外，隨著感染慢性病的人數增加，聚乙二醇化市場將因聚乙二醇化蛋白用於治療各種慢性病的使用增加而受到推動。聚乙二醇化分子具有許多優點，包括更長的半衰期、更低的毒性、更低的免疫原性和增強的蛋白水解保護，所有這些都有助於市場的持續擴張。但另一方面，聚乙二醇化製程成本的上升和某些藥物的專利到期預計將抑制市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球聚乙二醇化市場的各個細分市場進行了包容性評估。聚乙二醇化產業的成長和趨勢為本研究提供了整體方法。

市場區隔

聚乙二醇化市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品和服務

耗材
服務

按類型

群落刺激因子
干擾素
促紅血球生成素
重組因子VII
其他

按申請

癌症
自體免疫疾病
肝炎
多發性硬化症
血友病
胃腸道疾病
其他

按最終用戶

製藥與生物技術公司
合約研究組織
學術及研究機構
聚乙二醇化蛋白質

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲聚乙二醇化市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。聚乙二醇化市場的主要參與者包括Thermo Fisher Scientific Inc.、Abcam Plc、Enzon Pharmaceuticals Inc.、Merck KGaA、Celares GmbH、Profacgen、Creative PEGworks、NOF America Corp.、Aurigene Pharmaceutical Services Ltd.、Laysan Bio Inc. 。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品和服務分類的市場吸引力分析
- 按類型分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球聚乙二醇化市場分析：依產品與服務分類

按產品和服務分類的概述
按產品和服務進行歷史和預測資料分析
耗材
服務

第 6 章：全球聚乙二醇化市場分析：按類型

按類型概述
按類型分析歷史和預測數據
群落刺激因子
干擾素
促紅血球生成素
重組因子VII
其他

第 7 章：全球聚乙二醇化市場分析：依應用分類

概述：按應用
歷史與預測資料分析：按應用分類
癌症
自體免疫疾病
肝炎
多發性硬化症
血友病
胃腸道疾病
其他

第 8 章：全球聚乙二醇化市場分析：依最終用戶分類

最終用戶概述
最終用戶的歷史和預測數據分析
製藥與生物技術公司
合約研究組織
學術及研究機構
聚乙二醇化蛋白質

第 9 章：全球聚乙二醇化市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：聚乙二醇化公司的競爭格局

聚乙二醇化市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Abcam Plc

公司概況
公司收入
產品
最新動態

Enzon Pharmaceuticals Inc.

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

Celares GmbH

公司概況
公司收入
產品
最新動態

Profacgen

公司概況
公司收入
產品
最新動態

Creative PEGworks

公司概況
公司收入
產品
最新動態

NOF America Corp.

公司概況
公司收入
產品
最新動態

Aurigene Pharmaceutical Services Ltd.

公司概況
公司收入
產品
最新動態

Laysan Bio Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11216591

The global demand for PEGylation Market is presumed to reach the market size of nearly USD 5.8 Billion by 2032 from USD 2.03 Billion in 2023 with a CAGR of 12.36% under the study period 2024-2032.

PEGylation (or pegylation) is the process of attaching or amalgamating polyethylene glycol (PEG, also known as macrogol in pharmacy) polymer chains to molecules and macrostructures, such as medication, therapeutic protein, or vesicle, in both covalent and non-covalent ways. PEGylation is commonly accomplished by incubating the target molecule with a reactive PEG derivative. The covalent attachment of PEG to a medication or therapeutic protein can ''''hide'''' the agent from the host's immune system (reduce immunogenicity and antigenicity) and enhance its hydrodynamic size (size in solution), which extends its circulation duration by reducing renal clearance. Hydrophobic medicines and proteins can also be PEGylated to make them water-soluble.

MARKET DYNAMICS

Increased R&D investments by pharmaceutical and biopharmaceutical companies, expansion in the biologics industry, rising prevalence of lifestyle illness, and increased attention and awareness on improving protein stability and circulation half-life are projected to drive market growth. Furthermore, as the number of people infected with chronic diseases rise, the PEGylation market will be fueled by the increased usage of PEGylated protein to treat various chronic diseases. PEGylated molecules provide many advantages, including a longer half-life, decreased toxicity, lower immunogenicity, and increased proteolytic protection, all contribute to the market's continued expansion. But on the other side, rising PEGylation process costs and the patent expiration of certain medications are expected to stifle market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of PEGylation. The growth and trends of PEGylation industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the PEGylation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

Consumables
Services

By Type

Colony-stimulating Factor
Interferons
Erythropoietin
Recombinant Factor VII
Others

By Application

Cancer
Autoimmune Diseases
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorders
Others

By End-user

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutes
PEGylated Proteins

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the PEGylation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the PEGylation market include Thermo Fisher Scientific Inc., Abcam Plc, Enzon Pharmaceuticals Inc., Merck KGaA, Celares GmbH, Profacgen, Creative PEGworks, NOF America Corp., Aurigene Pharmaceutical Services Ltd., Laysan Bio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PEGYLATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Services
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PEGYLATION MARKET ANALYSIS BY PRODUCT & SERVICES

5.1. Overview By Product & Services
5.2. Historical and Forecast Data Analysis By Product & Services
5.3. Consumables Historic and Forecast Sales By Regions
5.4. Services Historic and Forecast Sales By Regions

6. GLOBAL PEGYLATION MARKET ANALYSIS BY TYPE

6.1. Overview By Type
6.2. Historical and Forecast Data Analysis By Type
6.3. Colony-stimulating Factor Historic and Forecast Sales By Regions
6.4. Interferons Historic and Forecast Sales By Regions
6.5. Erythropoietin Historic and Forecast Sales By Regions
6.6. Recombinant Factor VII Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PEGYLATION MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Cancer Historic and Forecast Sales By Regions
7.4. Autoimmune Diseases Historic and Forecast Sales By Regions
7.5. Hepatitis Historic and Forecast Sales By Regions
7.6. Multiple Sclerosis Historic and Forecast Sales By Regions
7.7. Hemophilia Historic and Forecast Sales By Regions
7.8. Gastrointestinal Disorders Historic and Forecast Sales By Regions
7.9. Others Historic and Forecast Sales By Regions

8. GLOBAL PEGYLATION MARKET ANALYSIS BY END-USER

8.1. Overview By End-user
8.2. Historical and Forecast Data Analysis By End-user
8.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
8.4. Contract Research Organizations Historic and Forecast Sales By Regions
8.5. Academic & Research Institutes Historic and Forecast Sales By Regions
8.6. PEGylated Proteins Historic and Forecast Sales By Regions

9. GLOBAL PEGYLATION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PEGYLATION COMPANIES

10.1. PEGylation Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PEGYLATION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Thermo Fisher Scientific Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Abcam Plc
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Enzon Pharmaceuticals Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Merck KGaA
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Celares GmbH
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Profacgen
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Creative PEGworks
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. NOF America Corp.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Aurigene Pharmaceutical Services Ltd.
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Laysan Bio Inc
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments